Amneal has struck a deal to acquire a majority 65.1% share in AvKARE, a US manufacturer and wholesaler that is “one of the largest private-label providers of generic pharmaceuticals in the US federal agency sector.”
Primarily focused on serving the US Department of Defense and Department of Veterans Affairs, AvKARE’s customer base also includes the US Army, Air Force, Navy
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?